Dr. Baskies, former Chairman of the national Board of Directors of the American Cancer Society, is a fellowship trained surgical oncologist with special interests in breast cancer, thyroid cancer, and melanoma. He received his Bachelor of Arts degree summa cum laude and was a member of Phi Beta Kappa at ...
Dr. Shepard was a recipient of the 2019 Lasker-DeBakey Clinical Medical Research Award in recognition of his research work in improving patient lives in the field of oncology. He also received the Warren Alpert Prize, an annual award granted by The Warren Alpert Foundation, for his pioneering research in the ...
Dr. Conejo-Garcia completed his medical degree at the University of Zaragoza, in Spain. After a residency in Clinical Chemistry, he completed his PhD in Molecular Medicine from the University of Alcala, also in Spain, in 1998. He completed post doctorate training in pancreatic cancer at the University of Bern, Switzerland, ...
Dr. Marco Davila is a medical oncologist in the Department of Blood and Marrow Transplantation. His clinical focus is utilizing cell therapies to treat patients with hematologic malignancies. He obtained his MD and PhD degrees at the Duke University School of Medicine and trained in medicine and medical oncology at ...
Dr. Abate‐Daga completed his undergraduate studies in clinical biochemistry at the Universidad Nacional de Córdoba (Argentina), and his PhD in Health and Life Sciences at the Pompeu Fabra University and Centre for Genomic Regulation (Barcelona, Spain). He completed post doctorate training in cancer immunotherapy and gene therapy, under the mentorship ...
Dr. Linda Kelley is a Senior Member and Director of the Cell Therapy facility at Moffitt Cancer Center. Previously she was the head of the Cell Therapy facility at Dana Farber Cancer Institute at Harvard. As director of the Cell Therapy Facility at Moffitt Cancer Center, Dr. Kelley is responsible ...
Dr. Ian Frazer is a professor at the University of Queensland where he leads a research team working at the Translational Research Institute (TRI) in Brisbane, Australia on the immunobiology of epithelial cancers. Additionally, he currently serves as the President of the Australian Academy of Health and Medical Sciences, and ...
Latest News & Events
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Read More...Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Read More...